Epharmix

Epharmix is a digital health company that provides a clinically-validated platform for remote patient monitoring and chronic disease management. The company's technology uses automated SMS and phone-based interventions to collect real-time data from patients, allowing healthcare providers to identify and manage high-risk individuals before complications arise. Epharmix offers specialized modules for a wide range of conditions, including heart failure, COPD, and diabetes, all of which have been tested in peer-reviewed clinical trials. In 2021, the company was acquired by CareSignal to expand its reach in the value-based care market.